NCT05120973View on ClinicalTrials.gov

Multispectral Fluorescence as a Tool to Separate Healthy and Disease Related Lymphatic Anatomies in Prostate Cancer.

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

April 25, 2024

Study Completion Date

July 24, 2024

Conditions

Prostate Cancer

Interventions

PROCEDURE

multispectral imaging

Sentinel node biopsy with Indocyanine Green -Technetium - Nanocolloid + fluorescein

PROCEDURE

fluorescence for lymphatic mapping

Indocyanine green injected in abdominal wall

Trial Locations (1)

1066 CX

Netherlands Cancer Institute, Amsterdam

All Listed Sponsors

lead

The Netherlands Cancer Institute

OTHER

NCT05120973 - Multispectral Fluorescence as a Tool to Separate Healthy and Disease Related Lymphatic Anatomies in Prostate Cancer. | Biotech Hunter | Biotech Hunter